SMARCD1 and cancer: In normal conditions, regulation by these two miRNAs likely fine tunes the expression of BAF60A to regulate BAF activity, but when the expression of either miRNA becomes aberrant as in the described cancers, this regulation likely impacts important BAF functions, such as its known tumor suppressor activity.